N/A N=55 Coherence Imaging of the Cervical Epithelium
Cervical Epithelia
Primary: Number of Patients With Interferometric Data Acquired From Cervical Epithelium — 3; 41 patients
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=34 Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
Cigarette Smoking
Primary: Change in Fagerstrom Test of Nicotine Dependence Score — .67; 1.33 score on a scale — p=0.39
Phase 3 N=300 Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants
Malaria
Primary: Prevalence of Placental Malaria — 49; 30; 26 Participants
Phase 1 N=24 A Study to Evaluate the Effect of Food on LY2216684
Depressive Disorder, Major
Primary: Pharmacokinetics: Area Under the Plasma Concentration-Time Curve From Time 0 to Infinity (AUC0-∞) of LY2216684 — 871; 861 nanogram*hour/milliliter (ng*h/mL)
N/A N=42 Ecological Effect of Arginine Dentifrice on Oral Microbiota
Dental Caries · Oral Bacterial Infection · Microbiota
Primary: The Change of Abundance of Specific Oral Microbes After Intervention as Assessed by 16S rRNA Sequencing — 0.00756; 0.14636; 0.00629; 0.11956 percentage of bacteria
N/A N=33 A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway
Intraoperative Ventilation
Primary: Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. — 55.2; 47 mmHg — p=.0051
N/A N=504 Protecta Smart Analysis Register
Patients With an Indication for an ICD Implantation According to the Guidelines
Primary: Analysis of Change of Episodes Inappropriately Treated by Shock Therapy Due to Smart Shock™ Technology. — 94.9 % of episodes wo shock due to SmartShock
Phase 3 N=89 Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure
HIV Infection
Primary: Proportion of Participants With Treatment Failure — 0.0682; 0.0667 proportion of participants
N/A N=25 Health Effects of Increasing Muscle Activation While Sitting in Office Workers
Blood Pressure
Primary: Blood Glucose — 5.60 mmol/L
Phase 3 N=205 Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
Migraine
Primary: Persistent Headache Pain Free at 24 Hours — 26; 19 Participants
Phase 2 N=42 Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
Carcinoma, Non-small-cell Lung
Primary: Radiographic Response Rates — 19 Participants
N/A N=19 Benefits of Tanning in Fibromyalgia Patients
Fibromyalgia Syndrome
Primary: Pain Relief Success Rates (Phase I) — 33; 16 percentage of exposures with relief
Phase 4 N=62 Comparison of Intra-articular Dexmedetomidine and Magnesium in Postoperative Pain
Postoperative Pain · Intra-articular Injection · Dexmedetomidine
Primary: Postoperative Pain — 0; 0.04; 0.19; 0.23 score on a scale
Phase 3 N=284 Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Liver Transplantation
Primary: Number of Participants With Composite Efficacy Failure of Treated Biopsy Proven Acute Rejection, Graft Loss or Death in Everolimus With Reduced Tacrolimus Group Compared…
Phase 2 N=49 Early Treatment for Acute ACL Tear
Anterior Cruciate Ligament (ACL) Tears
Primary: Participant Pain Assessment — -3.9; -2.2; -3.6; -4.3 units on a scale — p=0.33